Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar 15;12(3):589.
doi: 10.3390/microorganisms12030589.

Prevalence and Characteristics of Plasmid-Encoded Serine Protease EspP in Clinical Shiga Toxin-Producing Escherichia coli Strains from Patients in Sweden

Affiliations

Prevalence and Characteristics of Plasmid-Encoded Serine Protease EspP in Clinical Shiga Toxin-Producing Escherichia coli Strains from Patients in Sweden

Lei Wang et al. Microorganisms. .

Abstract

Shiga toxin-producing Escherichia coli (STEC) infection can cause a broad spectrum of symptoms spanning from asymptomatic shedding to mild and bloody diarrhea (BD) and even life-threatening hemolytic-uremic syndrome (HUS). As a member of the serine protease autotransporters of Enterobacteriaceae (SPATE) family, EspP has the ability to degrade human coagulation factor V, leading to mucosal bleeding, and also plays a role in bacteria adhesion to the surface of host cells. Here, we investigated the prevalence and genetic diversity of espP among clinical STEC isolates from patients with mild diarrhea, BD, and HUS, as well as from asymptomatic individuals, and assessed the presence of espP and its subtypes in correlation to disease severity. We found that 130 out of 239 (54.4%) clinical STEC strains were espP positive, and the presence of espP was significantly associated with BD, HUS, and O157:H7 serotype. Eighteen unique espP genotypes (GTs) were identified and categorized into four espP subtypes, i.e., espPα (119, 91.5%), espPγ (5, 3.8%), espPδ (4, 3.1%), and espPε (2, 1.5%). espPα was widely distributed, especially in strains from patients with BD and HUS, and correlated with serotype O157:H7. Serogroup O26, O145, O121, and O103 strains carried espPα only. Ten GTs were identified in espPα, and espPα/GT2 was significantly associated with severe disease, i.e., BD and HUS. Additionally, espP was strongly linked to the presence of eae gene, and the coexistence of espPα and stx2/stx2a + stx2c was closely related to HUS status. To sum up, our data demonstrated a high prevalence and genetic diversity of the espP gene in clinical STEC strains in Sweden and revealed an association between the presence of espP, espP subtypes, and disease severity. espP, particularly the espPα subtype, was prone to be present in more virulent STEC strains, e.g., "top-six" serotypes strains.

Keywords: Shiga toxin-producing Escherichia coli; clinical significance; espP gene; gene diversity; hemolytic uremic syndrome.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Phylogenetic relationships of 18 different espP sequences identified in this study and 15 espP subtypes reference sequences based on the Neighbor-Joining method. At each node, the black circles represent values of bootstraps that were more than 60. The corresponding espP subtype (number of strains), strain name, serotype (number of strains), stx subtype (number of strains), and ST types (number of strains) are shown. The espP subtypes/GTs in this study are indicated in bold and different colors. Scale bar indicates genetic distance.

Similar articles

References

    1. Zhang H., Yamamoto E., Murphy J., Carrillo C., Locas A. Shiga Toxin–Producing Escherichia coli (STEC) and STEC-Associated Virulence Genes in Raw Ground Pork in Canada. J. Food Prot. 2021;84:1956–1964. doi: 10.4315/JFP-21-147. - DOI - PubMed
    1. Giordano M., Iacoviello O., Santangelo L., Martino M., Torres D., Carbone V., Scavia G., Loconsole D., Chironna M., Cristofori F., et al. Gastrointestinal Involvement in STEC-Associated Hemolytic Uremic Syndrome: 10 Years in a Pediatric Center. Pediatr. Nephrol. 2024:1–7. doi: 10.1007/s00467-023-06258-5. - DOI - PMC - PubMed
    1. Mayer C.L., Leibowitz C.S., Kurosawa S., Stearns-Kurosawa D.J. Shiga Toxins and the Pathophysiology of Hemolytic Uremic Syndrome in Humans and Animals. Toxins. 2012;4:1261–1287. doi: 10.3390/toxins4111261. - DOI - PMC - PubMed
    1. Bielaszewska M., Mellmann A., Zhang W., Köck R., Fruth A., Bauwens A., Peters G., Karch H. Characterisation of the Escherichia coli Strain Associated with an Outbreak of Haemolytic Uraemic Syndrome in Germany, 2011: A Microbiological Study. Lancet Infect. Dis. 2011;11:671–676. doi: 10.1016/S1473-3099(11)70165-7. - DOI - PubMed
    1. Valilis E., Ramsey A., Sidiq S., DuPont H.L. Non-O157 Shiga Toxin-Producing Escherichia coli—A Poorly Appreciated Enteric Pathogen: Systematic Review. Int. J. Infect. Dis. 2018;76:82–87. doi: 10.1016/j.ijid.2018.09.002. - DOI - PubMed